🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Gram Negative Pneumonia

Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia. NCT07086391n/a1 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Polymyxin B Sulfate 25mg Jet Nebulization / Vibrating Mesh Nebulization Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951n/a50 sites📍 Hall in Tirol📍 Reutte📍 Vienna Infectopharm Arzneimittel GmbH Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV NCT06135350Phase 22 sites📍 Moscow📍 Moscow Gamaleya Research Institute of Epidemiology and Microbiolog… · Tests: Fluorothiazinone, tablets 300 mg at a dose of 2400 mg/day, Placebo Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study NCT06325293NA13 sites📍 Aarau📍 Basel📍 Bern Christoph Berger · Tests: Azithromycin Pfizer®, Placebo Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome NCT06511050Phase 1, Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Lumbrokinase Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis NCT03044223n/a1 site📍 Ulm University of Ulm Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria NCT07512596Phase 227 sites📍 Bengbu📍 Beijing📍 Chongqing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQD3524, Meropenem for injection, Colistimethate Sodium for Injection A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection NCT06966284n/a1 site📍 Taipei TTY Biopharm Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site📍 Phnom Penh Institut Pasteur du Cambodge " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation " NCT06602557Phase 21 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Amikacin, Standard of care NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia NCT07492771Phase 11 site📍 Seoul MicrobiotiX Co., Ltd · Tests: MP101, Antibiotics A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections NCT07206745NA1 site📍 Zhengzhou Henan University of Traditional Chinese Medicine · Tests: Fei Re Qing Granules, Placebo of Feireqing Granules Optimising TREATment for Severe Gram-Negative Bacterial Infections NCT07004049Phase 441 sites📍 Brisbane📍 Brisbane📍 Hangzhou National University of Singapore · Tests: Colistin/Polymyxin B + Sulbactam, Colistin/Polymyxin B + Tigecycline/Eravacycline, Colistin/Polymyxin B + Meropenem, Ce…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy